In several malignant tumors, including ovarian carcinoma, cholangiocarcinoma, mesothelioma, and breast cancer, GPC3 is down-regulated as a result of hypermethylation of the GPC3 promoter [48, 49, 52, 53]. This evidence concerns the gene GPC3 and cholangiocarcinoma.